Hypotonic-Hyporesponsive Episode (HHE) as an adverse event following immunization: Case definition and guidelines for data collection, analysis, and presentation

Vaccine

Volumn 22, Issue 5-6, 2004, Pages 563-568

  Bonhoeffer, Jan ^a   Gold, Michael S ^b   Heijbel, Harald ^c   Vermeer, Patricia ^d   Blumberg, Dean ^e   Braun, Miles ^f   De Souza Brito, Glacus ^g   Davis, Robert L ^h   Halperin, Scott ⁱ   Heininger, Ulrich ^a   Khuri Bulos, Najwa ^j   Menkes, John ^k   Nokleby, Hanne ^l  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b Paediatric Rehabilitation Department Women s and Children s Hospital Campus   (Australia)

^c SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^g University Medical School   (Brazil)

^h UNIVERSITY OF WASHINGTON   (United States)

ⁱ DALHOUSIE UNIVERSITY   (Canada)

^j JORDAN UNIVERSITY HOSPITAL   (Jordan)

^k CEDARS SINAI MEDICAL CENTER   (United States)

^l NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; INACTIVATED VACCINE; LIVE VACCINE; PERTUSSIS VACCINE; TETANUS TOXOID; TUMOR VACCINE;

CLINICAL FEATURE; CONCEPT FORMATION; DATA ANALYSIS; DISEASE ASSOCIATION; FOLLOW UP; HEALTH STATUS; HUMAN; HYPOREFLEXIA; HYPOTONIC HYPORESPONSIVE EPISODE; IMMUNIZATION; INFORMATION PROCESSING; MUSCLE HYPOTONIA; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SYMPTOM; TIME; VACCINATION REACTION;

EID: 9144251966     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2003.09.009     Document Type: Article

References (22)

1. Braun M.M., Terracciano G., Salive M.E.et al. Report of a US public health service workshop on hypotonic-hyporesponsive episode (HHE) after pertussis immunization. Pediatrics. 102:1998;E52.
2. Cody C.L., Baraff L.J., Cherry J.D.et al. Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics. 68:1981;650-660.
3. Heijbel H., Ciofi degli Atti M.C., Harzer E.et al. Hypotonic hyporesponsive episodes in eight pertussis vaccine studies. Dev. Biol. Standard. 89:1997;101-103.
4. Schmitt H.J., Schuind A., Knuf M.et al. Clinical experience of a tricomponent acellular pertussis vaccine combined with diphtheria and tetanus toxoids for primary vaccination in 22,505 infants. J. Pediatr. 129:1996;695-701.
5. Rosenthal S., Chen R.T., Hadler S. The safety of acellular pertussis vaccine vs whole cell pertussis vaccine. Arch Pediatr. Adolesc. Med. 150:1996;457-460.
6. Gold M.S., Kempe A., Osbourn M. A comparison of serious adverse reactions to whole cell and acellular pertussis vaccines in South Australia. Med. J. Aust. 171:1999;331-332.
7. Miller E. Overview of recent trials of acellular pertussis vaccine. Biologicals. 27:1999;79-86.
8. Hannik CA, Cohen H. Pertussis vaccine experience in the Netherlands. In: Proceedings of the Third International Symposium on Pertussis, Bethesda, 1978, vol. 79(1830). Washington: DHEW Publications; 1979. p. 279-82.
9. Ström J. Further experience of reactions especially of a cerebral nature in conjunction with triple vaccination. Br. Med. J. 4:1967;320.
10. Goodwin H., Nash M., Gold M.et al. Vaccination of children following a previous hypotonic-hyporesponsive episode. J. Paediatr. Child Health. 35:1999;549-552.
11. Vermeer-de Bondt P., Labadie J., Rumke H.C. Rate of recurrent collapse after vacination with whole cell pertussis vaccine: follow-up study. Br. Med. J. 316:1998;902-903.
12. Vermeer-de Bondt P. Adverse Events Following Immunisation under the National Vaccination Program of the Netherlands. RIVM reports in 2000, Bilthoven, The Netherlands, 2002.
13. Blumberg D.A., Mink C.M., Lewis K.et al. Pathophysiology of reactions associated with pertussis vaccine. Dev. Biol. Standard. 73:1991;289-295.
14. Vermeer-de Bondt P. Adverse events following immunisation under the National Vaccination Program of the Netherlands. RIVM reports in 1995. Bilthoven, The Netherlands 2001.
15. Gold R., Scheiffele D., Halperin S., Dery P., Law B., Lebel M. Hypotonic-Hyporesponsive eoisodes in children hospitalized at 10 Canadian pediatric tertiary-care centers, 1991-1994. Can. Commun. Dis. Rep. 23:1997;73-76.
16. DuVernoy T.S., Braun M.M. Hypotonic-hyporesponsive episodes reported to the vaccine adverse event reporting system (VAERS), 1996-1998. Pediatrics. 106:2000;E52.
17. Blumberg D.A., Lewis K., Mink C.M.et al. Severe reactions associated with diphtheriatetanus-pertussis vaccine: detailed study of children with seizures, hypotonic-hyporesponsive episodes, high fevers, and persistent crying. Pediatrics. 91:1993;1158-1165.
18. Sauer L. Whooping cough: a study in immunisation. JAMA. 100:1933;239-241.
19. Blumberg D.A., Morgan C.A., Lewis K.et al. An ongoing surveillance study of persistent crying and hypotonic-hyporesponsive episodes following routine DTP immunization: a preliminary report. Tokai. J. Exp. Clin. Med. 131:1988;133-136.
20. Braun M., Patriarca P., Ellenberg S. Syncope after Immunization. Arch. Pediatr. Adolesc. Med. 151:1997;255-259.
21. Baraff L.J., Shields W.D., Beckwith L.et al. Infants and children with convulsions and hypotonic-hyporesponsive episodes following diphtheria-tetanus- pertussis immunization: follow-up evaluation. Pediatrics. 81(6):1988;789-794.
22. The CONSORT statement and MOOSE, Available at: http://www.consort- statement.org/ .